Literature DB >> 34156769

Prevalence of depression and anxiety disorders following mild traumatic brain injury.

Richard L Delmonico1, Brian R Theodore1, M Elizabeth Sandel2, Mary Anne Armstrong3, Michelle Camicia1.   

Abstract

BACKGROUND: Previous studies have identified an association between traumatic brain injuries and the development of psychiatric disorders in general. However, these studies were subject to limitations that demonstrate the need for a study of a large, clearly defined mild traumatic brain injury (mTBI) population within an integrated healthcare system.
OBJECTIVE: To determine the prevalence and relative risk of postinjury affective disorders over 4 years following mTBI.
DESIGN: Cohort study of mTBI cases and matched controls, over a 4-year period.
SETTING: An integrated healthcare delivery system in California. PATIENTS: A total of 9428 adult health plan members diagnosed with mTBI from 2000-2007 and enrolled in the year before injury, during which no TBI was ascertained. Control participants included 18,856 individuals selected based on the following criteria: Two unexposed health plan members per each mTBI-exposed patient were randomly selected and individually matched for age, gender, race/ethnicity, and medical comorbidities.
INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: A diagnosis of affective disorder (depressive, anxiety, and adjustment disorders) in the 4 years after mTBI or the reference date, determined according to the International Classification of Diseases, Ninth Revision, Clinical Modification as well as the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision.
RESULTS: Affective disorders were most prominent during the first 12 months with 23% following mTBI and 14% in the control group. Four-year aggregate adjusted odds ratios for having an affective disorder following mTBI were 1.2 (95% CI: 1.1, 1.2; p < .001) and 1.5 (95% CI: 1.5, 1.6; p < .001) for patients with and without prior affective disorders, respectively.
CONCLUSION: mTBI was associated with a significantly increased risk of having subsequent affective disorders. Screening for and addressing affective disorders at earlier stages following the injury is an important step to avoid persisting conditions that may pose a barrier to full recovery.
© 2021 American Academy of Physical Medicine and Rehabilitation.

Entities:  

Mesh:

Year:  2021        PMID: 34156769     DOI: 10.1002/pmrj.12657

Source DB:  PubMed          Journal:  PM R        ISSN: 1934-1482            Impact factor:   2.218


  5 in total

1.  Sex differences in outcomes from mild traumatic brain injury eight years post-injury.

Authors:  Nicola Jayne Starkey; Brittney Duffy; Kelly Jones; Alice Theadom; Suzanne Barker-Collo; Valery Feigin
Journal:  PLoS One       Date:  2022-05-27       Impact factor: 3.752

2.  Early Changes in the White Matter Microstructure and Connectome Underlie Cognitive Deficit and Depression Symptoms After Mild Traumatic Brain Injury.

Authors:  Wenjing Huang; Wanjun Hu; Pengfei Zhang; Jun Wang; Yanli Jiang; Laiyang Ma; Yu Zheng; Jing Zhang
Journal:  Front Neurol       Date:  2022-06-30       Impact factor: 4.086

3.  Effectiveness of a guideline implementation tool for supporting management of mental health complications after mild traumatic brain injury in primary care: protocol for a randomised controlled trial.

Authors:  Noah D Silverberg; Thalia Otamendi; Penelope Ma Brasher; Jeffrey R Brubacher; Linda C Li; Pierre-Paul Lizotte; William J Panenka; Frank X Scheuermeyer; Patrick Archambault
Journal:  BMJ Open       Date:  2022-06-21       Impact factor: 3.006

4.  Reframing postconcussional syndrome as an interface disorder of neurology, psychiatry and psychology.

Authors:  Camilla N Clark; Mark J Edwards; Bee Eng Ong; Luke Goodliffe; Hena Ahmad; Michael D Dilley; Shai Betteridge; Colette Griffin; Peter O Jenkins
Journal:  Brain       Date:  2022-06-30       Impact factor: 15.255

5.  Incidence of Depression after Traumatic Brain Injury: A Nationwide Longitudinal Study of 2.2 Million Adults.

Authors:  Yoonjeong Choi; Eun Young Kim; Jiyu Sun; Han-Kyoul Kim; Ye Seol Lee; Byung-Mo Oh; Hye Yoon Park; Ja-Ho Leigh
Journal:  J Neurotrauma       Date:  2022-02-02       Impact factor: 5.269

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.